Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Herman

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
American Journal of Epidemiology|January 12, 1999
Estimating prevalence of type 1 and type 2 diabetes in a population of African Americans with diabetes mellitusJ P Boyle, M M Engelgau, T J Thompson, et al.
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|June 4, 1993
Surveillance for diabetes mellitus--United States, 1980-1989L S Geiss, W H Herman, M G Goldschmid, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1995
Diabetes mellitus in Egypt: risk factors and prevalenceW H Herman, M A Ali, R E Aubert, et al.
Academic Radiology|February 15, 2016
Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson DiseaseM Petrou, C Davatzikos, M Hsieh, et al.
Diabetes Care|August 1, 1993
Cost-benefit analysis of preconception care for women with established diabetes mellitusA Elixhauser, J M Weschler, J L Kitzmiller, et al.
Diabetes Care|February 1, 1995
Diabetes and pregnancy. Factors associated with seeking pre-conception careN K Janz, W H Herman, M P Becker, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 23, 2006
A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and EuropeG Viberti, J Lachin, R Holman, et al.
Diabetes Care|May 1, 1997
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemiaR C Eastman, J C Javitt, W H Herman, et al.
The Journal of Clinical Endocrinology and Metabolism|February 24, 2015
The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-upV R Aroda, C A Christophi, S L Edelstein, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 31, 2016
Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) studyS M Lenherr, J Q Clemens, B H Braffett, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
American Journal of Epidemiology|January 12, 1999
Estimating prevalence of type 1 and type 2 diabetes in a population of African Americans with diabetes mellitusJ P Boyle, M M Engelgau, T J Thompson, et al.
MMWR. CDC Surveillance Summaries : Morbidity and Mortality Weekly Report. CDC Surveillance Summaries|June 4, 1993
Surveillance for diabetes mellitus--United States, 1980-1989L S Geiss, W H Herman, M G Goldschmid, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|December 1, 1995
Diabetes mellitus in Egypt: risk factors and prevalenceW H Herman, M A Ali, R E Aubert, et al.
Academic Radiology|February 15, 2016
Diabetes, Gray Matter Loss, and Cognition in the Setting of Parkinson DiseaseM Petrou, C Davatzikos, M Hsieh, et al.
Diabetes Care|August 1, 1993
Cost-benefit analysis of preconception care for women with established diabetes mellitusA Elixhauser, J M Weschler, J L Kitzmiller, et al.
Diabetes Care|February 1, 1995
Diabetes and pregnancy. Factors associated with seeking pre-conception careN K Janz, W H Herman, M P Becker, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 23, 2006
A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of Type 2 diabetic patients in North America and EuropeG Viberti, J Lachin, R Holman, et al.
Diabetes Care|May 1, 1997
Model of complications of NIDDM. II. Analysis of the health benefits and cost-effectiveness of treating NIDDM with the goal of normoglycemiaR C Eastman, J C Javitt, W H Herman, et al.
The Journal of Clinical Endocrinology and Metabolism|February 24, 2015
The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-upV R Aroda, C A Christophi, S L Edelstein, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 31, 2016
Glycaemic control and risk of incident urinary incontinence in women with Type 1 diabetes: results from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) studyS M Lenherr, J Q Clemens, B H Braffett, et al.
Pageof 11